5611 Results

People

  1. Giralt
    Giralt
  2. Ladanyi
    Ladanyi
  3. Arcila
    Arcila
  4. Perales
    Perales
  5. Drilon
    Drilon
  6. Hyman
    Hyman
  7. Berger
    Berger
  8. Solit
    Solit
  9. Motzer
    Motzer
  10. Reis-Filho
    Reis-Filho

Groups

  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)
  7. Center for Hematologic Malignancies (914)
  8. Survivorship Research (909)
  9. Department of Pathology and Laboratory Medicine (784)
  10. Population Sciences Research Program (751)
  1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Primary and secondary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)
    Meeting Abstract

    Pernas, S.; Villagrasa, P.; Nuciforo, P. G.; Vivancos, A.; Scaltriti, M.; Rodon, J.; Burgues, O.; Canes, J.; Duenas, M.; Cecchi, F.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K.; Grkovski, M.; Tang, K.; Humm, J. L.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A. D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment of metastasis (TMEM) score in residual breast carcinoma post-neoadjuvant chemotherapy as an independent prognosticator of distant recurrence
    Meeting Abstract

    Oktay, M. H.; D'Alfonso, T.; Ginter, P.; Lanjewar, S.; Entenberg, D.; Pastoriza, J. M.; Wang, Y.; Lin, Y.; Karagiannnis, G. S.; Lin, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Recurrent but not pathognomonic fusion genes in mucinous carcinomas of the breast
    Meeting Abstract

    Pareja, F.; Gularte-Merida, R.; Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Piscuoglio, S.; Marchio, C.; Vincent-Salomon, A.; Brogi, E.; Weigelt, B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Metaplastic breast carcinomas and uterine carcinosarcomas are histologically and genetically related
    Meeting Abstract

    Da Cruz Paula, A.; Brown, D.; Geyer, F. C.; Smith, E.; Pareja, F.; Papanastasiou, A. D.; Fusco, N.; Marchio, C.; Brogi, E.; Wen, H. Y.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
    Meeting Abstract

    Liu, Y. L.; Bager, C. L.; Willumsen, N.; Kornhauser, N.; Cobham, M.; Andreopoulou, E.; Cigler, T.; Moore, A.; LaPolla, D.; Fitzpatrick, V.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304
    Meeting Abstract

    Mamounas, E. P.; Bandos, H.; White, J. R.; Julian, T. B.; Khan, A. J.; Shaitelman, S. F.; Torres, M. A.; Vicini, F. A.; Ganz, P. A.; McCloskey, S. A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Lymphedema management in 2018: Are we making any progress?
    Meeting Abstract

    Mehrara, B.
    Cancer Research (2019)

    Fulltext@MSK | Save